Role for highly regulated rep gene expression in adeno-associated virus vector production

被引:176
作者
Li, JA
Samulski, RJ
Xiao, XA
机构
[1] UNIV N CAROLINA,GENE THERAPY CTR,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,DEPT PHARMACOL,CHAPEL HILL,NC 27599
[3] SOMATIX THERAPY CORP,ALAMEDA,CA 94501
关键词
D O I
10.1128/JVI.71.7.5236-5243.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent success achieving long-term in vivo gene transfer without a significant immune response by using adeno-associated virus (AAV) vectors (X. Xiao, J, Li, and R. J. Samulski, J, Virol. 70:8098-8108, 1995) has encouraged further development of this vector for human gene therapy. Currently, studies focus on the generation of high-titer vectors by using the two-plasmid helper-vector system in adenovirus (Ad)-infected cells. To examine the effects of the AAV replication (rep) genes on recombinant AAV (rAAV) vector production, we have constructed a series of AAV helper plasmids that contain strong heterologous promoters in place of the endogenous p5 promoter. Although high-level rep gene expression was achieved, rAAV DNA failed to replicate in the absence of Ad infection. Moreover, unregulated overexpression of Rep78/68 led to substantially lower rAAV yields in the presence of Ad (10(4-5) versus 10(7-8)). In contrast, under similar conditions, reduced Rep78/68 expression resulted in much higher rAAV yields (10(9)). Molecular characterization showed that overexpression of the rep gene decreased rAAV DNA replication and severely inhibited capsid (eap) gene expression. Interestingly, a reduced rep level enhanced cnp gene expression and supported normal rAAV DNA replication. These studies suggest a critical role for regulated rep gene expression in rAAV production and have facilitated the development of a new AAV helper plasmid that increases vector production eightfold over currently used constructs.
引用
收藏
页码:5236 / 5243
页数:8
相关论文
共 57 条
[1]   ADENOASSOCIATED VIRUS REP PROTEIN INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRODUCTION IN HUMAN-CELLS [J].
ANTONI, BA ;
RABSON, AB ;
MILLER, IL ;
TREMPE, JP ;
CHEJANOVSKY, N ;
CARTER, BJ .
JOURNAL OF VIROLOGY, 1991, 65 (01) :396-404
[2]   EXPRESSION FROM THE ADENO-ASSOCIATED VIRUS-P5 AND VIRUS-P19 PROMOTERS IS NEGATIVELY REGULATED IN TRANS BY THE REP PROTEIN [J].
BEATON, A ;
PALUMBO, P ;
BERNS, KI .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4450-4454
[3]  
BERNS K.I., 1990, Virology, V2, P1743
[4]   Adenovirus and adeno-associated virus as vectors for gene therapy [J].
Berns, KI ;
Giraud, C .
DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 :95-104
[5]   ADENOASSOCIATED VIRUSES - AN UPDATE [J].
BERNS, KI ;
BOHENZKY, RA .
ADVANCES IN VIRUS RESEARCH, 1987, 32 :243-306
[6]  
BERNS KI, 1996, VIROLOGY, V2, P2173
[7]   PROPERTIES OF AN ADENOVIRUS TYPE-2 MUTANT, AD2DL807, HAVING A DELETION NEAR THE RIGHT-HAND GENOME TERMINUS - FAILURE TO HELP AAV REPLICATION [J].
CARTER, BJ ;
MARCUSSEKURA, CJ ;
LAUGHLIN, CA ;
KETNER, G .
VIROLOGY, 1983, 126 (02) :505-516
[8]   MUTAGENESIS OF AN AUG CODON IN THE ADENO-ASSOCIATED VIRUS REP GENE - EFFECTS ON VIRAL-DNA REPLICATION [J].
CHEJANOVSKY, N ;
CARTER, BJ .
VIROLOGY, 1989, 173 (01) :120-128
[9]   Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor [J].
Dobner, T ;
Horikoshi, N ;
Rubenwolf, S ;
Shenk, T .
SCIENCE, 1996, 272 (5267) :1470-1473
[10]   Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors [J].
Ferrari, FK ;
Samulski, T ;
Shenk, T ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3227-3234